SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI CRYPTO is trending as its dedicated community actively rallies around the powerful "We All Gonna Make It" ethos, fostering strong belief in its long-term potential. Supporters are consistently accumulating and emphasizing patience, viewing it as a generational opportunity rooted in collective building and positive sentiment within the crypto space.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash (BCH) is drawing significant attention following its reported integration-ready Post-Quantum Vault, positioning it as a secure and scalable blockchain that has recently shown relative strength against broader market trends. The community is actively discussing its potential for a major breakout, with many believing BCH is severely undervalued given its low transaction fees and efficiency, envisioning a parabolic run and even outperforming Bitcoin in the long term. This bullish sentiment is further amplified by expectations of an upcoming altcoin season and regulatory clarity.

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.

U.S. Physical Therapy, Inc.

U.S. Physical Therapy (USPH) is trending due to a wave of analyst upgrades and recent acquisitions, significantly expanding its outpatient clinic network. The community is actively debating the company's valuation, with discussions around its growth-by-acquisition strategy and resilience in navigating sector-specific challenges, including shifts in Medicare reimbursement rates.

Monro, Inc. engages in the operation of chain stores that provide automotive undercar repair and tire services. It also offers services for brakes, mufflers and exhaust systems, and steering, drive train, suspension and wheel alignment. It operates under the brand names Monro Auto Service and Tire Centers, Tire Choice Auto Service Centers, Mr. Tire Auto Service Centers, Car-X Tire & Auto, Tire Warehouse Tires for Less, Ken Towery’s Tire & Auto Care, Tire Barn Warehouse, and Free Service Tire and Auto Centers. The company was founded by Charles J. August in 1957 and is headquartered in Fairport, NY.

Monro Inc

Monro Inc. (MNRO) is trending after exceeding adjusted EPS expectations in its latest quarterly financial results and providing a strong preliminary outlook for comparable store sales. Community sentiment is largely focused on this positive performance, further buoyed by reports of a notable activist investor taking a significant stake, which analysts view as a bullish signal for the auto service industry player.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending with strong institutional interest, underscored by major financial institutions reportedly filing for Solana ETFs, signaling increased mainstream adoption. The community is buzzing about its robust network activity, low fees, and thriving memecoin ecosystem, fueling a narrative of outperformance and strong bullish sentiment within the crypto space.

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

MBX Biosciences Inc.

MBX Biosciences is actively trending following positive Phase 2 data for its hypoparathyroidism treatment, canvuparatide, which met its primary endpoint and showed a compelling responder rate. This has generated significant bullish sentiment and numerous analyst upgrades, with the community anticipating substantial upside and potential strategic developments. However, an impending public offering and cautious outlooks from some firms regarding the data and competitive landscape are also central to current discussions.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint &amp; redeem rTokens.

StaFi

StaFi (FIS) is generating significant community buzz, primarily driven by persistent rumors of new major exchange listings, notably Coinbase, and noticeable increases in trading volume. The community is actively discussing its token burn proposal for deflationary tokenomics, an updated roadmap, and its core utility as a liquid staking protocol with AI-integrated and cross-chain bridging technology, anticipating substantial "altseason" gains due to its perceived undervaluation and low market cap.

The White Whale

WHITEWHALE CRYPTO is strongly trending on CryptoTwits, fueled by robust trading volume and an enthusiastic "WAGMI" community actively discussing its consistent price action and growing holder base. Its unique tokenomics, including a significant portion of its supply locked, and its emergence as a notable meme coin on the Solana network are key talking points driving current interest.

Novo

Novo is experiencing strong bullish sentiment driven by the anticipation of a major collaboration announcement related to its breakthrough in a universal influenza vaccine, which the community believes will attract significant partnerships. Investors are actively discussing the potential for multi-billion dollar deals, further solidifying Novo's competitive position amidst its ongoing advancements in the weight loss drug market.

AIXBT is an AI agent and driven crypto market intelligence platform designed to provide token holders with a strategic edge in the rapidly evolving crypto space. Leveraging advanced narrative detection and alpha-focused analysis, AIXBT automates the process of tracking and interpreting market trends, helping users gain actionable insights. This project emphasizes integrating various data sources and platforms for comprehensive analysis and decision-making.

aixbt by Virtuals

AIXBT is gaining significant attention following Virtuals' strategic pivot to an AI-centric ecosystem, focused on developing agent infrastructure and funding related teams. The community is highly optimistic, discussing a notable investment from Quantum Cats Treasury and speculating on its future as a leading AI token, even anticipating interest from major institutional players.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Emergent Biosolutions (NYSE:EBS) Reaches New 52-Week High - Time to Buy?

Emergent Biosolutions (NYSE:EBS) Hits New 52-Week High - Time to Buy...

Silver Oak Securities Incorporated Purchases New Position in Emergent Biosolutions Inc. $EBS

Silver Oak Securities Incorporated purchased a new stake in Emergent Biosolutions Inc. (NYSE:EBS - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities...

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Emergent Biosolutions (NYSE:EBS) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened...

Assenagon Asset Management S.A. Has $498,000 Stock Position in Emergent Biosolutions Inc. $EBS

Assenagon Asset Management S.A. lessened its stake in Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 81.8% in the third quarter, according to the company in its most recent disclosure with...

Emergent Biosolutions (NYSE:EBS) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why

Emergent Biosolutions (NYSE:EBS) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why...

Emergent Biosolutions (NYSE:EBS) Earns Buy Rating from HC Wainwright

HC Wainwright reaffirmed a "buy" rating and issued a $15.00 price objective on shares of Emergent Biosolutions in a research note on Tuesday...

Ronald Richard Sells 21,984 Shares of Emergent Biosolutions (NYSE:EBS) Stock

Emergent Biosolutions Inc. (NYSE:EBS - Get Free Report) Director Ronald Richard sold 21,984 shares of the business's stock in a transaction dated Friday, December 5th. The stock was sold at an...

Emergent Biosolutions (NYSE:EBS) Director Sells $263,148.48 in Stock

Emergent Biosolutions Inc. (NYSE:EBS - Get Free Report) Director Ronald Richard sold 21,984 shares of the company's stock in a transaction on Friday, December 5th. The stock was sold at an average...

Emergent Biosolutions Inc. $EBS Stock Holdings Increased by Geode Capital Management LLC

Geode Capital Management LLC grew its position in shares of Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 108.9% during the second quarter, according to the company in its most recent 13F...

Qiagen (QGEN) Up 6.3% Since Last Earnings Report: Can It Continue?

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$12.96
Prev Close	$13.36
Open	$13.36
Dividend Yield	0.00%
50-Day Moving Average	$11.50
Beta	2.17
Avg. Volume	808,644.00
PE Ratio	10.02

52-Week High	$14.06
52-Week Low	$4.02
Market Capitalization	$717.7M
EPS (Annual)	-$3.60
Price to Book	1.17
Revenue Per Employee	$1.16M
Enterprise Value/EBITDA	N/A

EBS
Emergent Biosolutions Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EBS News

EBSEmergent Biosolutions Inc